Therapeutic potential of insulin-like growth factor 2 in Huntington's disease: controlling proteostasis to alleviate the load of misfolded protein
Artículo
Open/
Therapeutic.pdf (852.5Kb)Access note
Acceso abierto
Publication date
2021Metadata
Show full item record
Cómo citar
Cómo citar
Therapeutic potential of insulin-like growth factor 2 in Huntington's disease: controlling proteostasis to alleviate the load of misfolded protein
Patrocinador
Agencia Nacional de Investigacion y Desarrollo (ANID) 15150012
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDAP 15150012
Takeda Pharmaceutical Company Ltd P09-015-F
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDEF ID16I10223
D11E1007
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT 1180186
1191003
United States Department of Defense
Air Force Office of Scientific Research (AFOSR) 20RT0419
Consejo Nacional de Ciencia y Tecnologia (CONACyT)
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) 21160843
Michael J Fox For Parkinson's Research Target 12473.01
Indexation
Artículo de publícación WoS
Quote Item
Neural Regeneration Research Vol 16 No. 8 August 2021
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States